-
Mashup Score: 9
Zach Klaassen and Zach Reardon delve into the nuances of managing nonmetastatic castration-resistant prostate cancer (nmCRPC) in clinical practice. Dr. Reardon discusses the evolving landscape of nmCRPC treatment, emphasizing the significance of early detection and the impact of advancing imaging technologies like PSMA PET scans on patient categorization. He advocates for treating patients with…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
Prostate cancer, stereotactic body radiotherapy (SBRT), Urethra-Sparing Stereotactic Body Radiotherapy, Urethra-Sparing Stereotactic Body Radiotherapy for Prostate Cancer, magnetic resonance guided radiotherapy (MRgRT).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 20Comparing Cost-Effectiveness of Surgery, Radiation, and Chemo for Seminoma - Daniel Joyce - 1 day(s) ago
Ruchika Talwar interviews Daniel Joyce about his journey into cost-effectiveness studies, particularly in testicular cancer. Initially skeptical, Dr. Joyce now sees these studies as crucial for interpreting clinical trial data in real-world contexts. He discusses his analysis of the SEMS trial, focusing on small-volume stage two seminoma, where RPLND emerged as the most cost-effective option…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
Rashid Sayyid and Zach Klaassen delve into the significance of racial disparities in prostate cancer treatment through a subgroup analysis of the ARASENS trial, which notably focused on Black patients. This pivotal trial assessed the efficacy of adding darolutamide to ADT and docetaxel in metastatic hormone-sensitive prostate cancer, revealing that Black patients, despite historically higher…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5The Use of Imaging in Staging Localized Prostate Cancer: A Case Study on High-Risk Localized Prostate Cancer - Zachary Klaassen - 1 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Zachary Klaassen, MD, MSc, Urologic Oncologist, Assistant Professor Surgery/Urology at the Medical College of Georgia at Augusta University, Well Star MCG, Georgia Cancer Center, Augusta, GA Neal D….
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Join Neal Shore @CURCMB, and @zklaassen_md @GACancerCenter as they delve into the groundbreaking use of PSMA PET imaging in high-risk localized #ProstateCancer. Learn how this innovative technology is transforming patient care. #WatchNow > https://t.co/iCBdBAzf5i @BayerPharma https://t.co/naUJmf3PSG
-
-
Mashup Score: 3The Impact of Advanced Imaging on Detection and Treatment in Nonmetastatic CRPC - Vahan Kassabian - 1 day(s) ago
Zach Klaassen engages in a discussion with Vahan Kassabian about the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC) management. They delve into how novel imaging techniques, particularly PSMA PET scans, have significantly narrowed the nmCRPC space by identifying metastases not detected by traditional imaging. Dr. Kassabian highlights the importance of PSA…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 20
Ashish Kamat and Mark Tyson discuss the currently enrolling PIVOT-006 study. Dr. Tyson discusses cretostimogene grenadenorepvec, a conditionally replicating oncolytic adenovirus designed for cancer cell destruction and immunotherapeutic effects. Highlighting four pivotal studies demonstrating the agent’s efficacy, especially in BCG unresponsive populations, Dr. Tyson outlines the development of…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
metastatic castration-sensitive prostate cancer (mCSPC), apalutamide treatment effect in TITAN patients with mCSPC, phase III randomised TITAN study, robust benefit with apalutamide plus ADT.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 11Drug Shortages: Why Are They a Recurrent Issue and What Can Regulatory Do to Prevent Them? - Chana Weinstock - 2 day(s) ago
Ruchika Talwar speaks with Chana Weinstock about the recent chemotherapy shortage affecting genitourinary cancers, notably muscle-invasive bladder cancer. Dr. Weinstock explains the complexity behind drug shortages, highlighting the manufacturing challenges of older, off-patent drugs like cisplatin and carboplatin. She discusses the FDA’s limitations in mandating production increases and its…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Robot-Assisted PSMA-Radioguided Surgery, Prostate Cancer, radical prostatectomy, Confocal microscopy, PSMA PET/CT, 68Ga-PSMA-11, robot-assisted radical prostatectomy (RARP), pelvic lymph node dissection (PLND), AURA 10 specimen PET/CT imager, XEOS Medical NV.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in #ProstateCancer patients: Report on three cases using an intraoperative PET-CT specimen imager. #BeyondTheAbstract with @oderdam @cittasalute_to > https://t.co/5W2v4comUa @urogoldjournal https://t.co/mIS13CoafT
-
Managing nonmetastatic castration-resistant #ProstateCancer. Zachary Reardon, MD joins @zklaassen_md @GACancerCenter to discuss the nuances of managing #nmCRPC in clinical practice. #WatchNow > https://t.co/eMWTzvMqPs https://t.co/ndmyEnTWB4